PerturbME
Target screening with a new sample-efficient perturbation and Co-Scientist.
An environment for imaging-centric biomedical discovery and lab automation.
Anti-PD1 and JAK2 inhibition help cure prostate cancer by reshaping inflammation.
Reliable agent verification with sequential hypothesis testing.
Scaling aging hypothesis testing across global experimental evidence.
A general-purpose biomedical agent.
A dedicated harness for spatial biology.
Stress-testing the metrics for cell foundation models.
Charting how AI is transforming scientific discovery.
Geometry and structural learning on molecules.
Privacy-preserving distributed training for COVID-19 diagnosis across 23 hospitals.
Self-supervised pre-training via occlusion completion.
A transistor that switches more sharply than the conventional limit.